It was presumed that the underlying mechanism by which GGT5 affects the prognosis of GC patients might be associated with metabolic regulation, immune modulation, and antioxidant effects (Wei et al., 2020; Wen et al., 2020; Ye et al., 2021). Here, GGT5 is linked to gastric cancer.